1-4 of 4
noscapine
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety Profile and Observed Drug Interaction of Noscapine and Vincristine in Combination In Vivo

Catherine Gordon, MD, Alan Nolan, Wanda Dorsett-Martin, DVM, Gail C. Megason, MD, Laree Hiser, PhD
Journal: Blood
Blood (2011) 118 (21): 5012.
https://doi.org/10.1182/blood.V118.21.5012.5012
Published: 2011
Journal Articles

Drug-resistant T-lymphoid tumors undergo apoptosis selectively in response to an antimicrotubule agent, EM011

Ritu Aneja, Jun Zhou, Surya N. Vangapandu, Binfei Zhou, Ramesh Chandra, Harish C. Joshi
Journal: Blood
Blood (2006) 107 (6): 2486–2492.
https://doi.org/10.1182/blood-2005-08-3516
Published: 2006
Journal Articles

Phase I Study of Noscapine for Patients with Non-Hodgkin’s Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy.

Anil Tulpule, MD, Alexandra M. Levine, MD, Nancy E. Berman, RN, BSN, Lynne Smith, PhD, Alan Auerbach, Dan Douer, MD
Journal: Blood
Blood (2005) 106 (11): 3341.
https://doi.org/10.1182/blood.V106.11.3341.3341
Published: 2005
Journal Articles

Oral Administration of the Opium Alkaloid Noscapine (NOS) Exhibits Potent Anti-Tumor Activity Against Non-Hodgkin’s Lymphomas and Myeloma Cell Lines In Vitro and In Vivo in SCID-beige Murine Xenograft Models.

Owen O’Connor, MD, PhD, J. Mastrella, E. Smith, L. Toner, A. Auerbach, J. P. Leonard, MD
Journal: Blood
Blood (2005) 106 (11): 2427.
https://doi.org/10.1182/blood.V106.11.2427.2427
Published: 2005